Solid Formulations are a solid body drug delivery system of various weights and shapes, adapted for introduction into orifices of the human body.4 The external membrane of the suppository will typically melt, soften, or dissolve at body temperature which allows the active ingredient to then be absorbed by the surrounding tissue. Suppository bases usually employed are cocoa butter, glycerinated gelatin, hydrogenated vegetable oils, mixtures of polyethylene glycols of various molecular weights, and fatty acid esters of polyethylene glycol. The suppository base employed has a marked influence on the release of the active ingredient incorporated in it.
This report contains market size and forecasts of Solid Formulations Drug Delivery in Global, including the following market information:
- Global Solid Formulations Drug Delivery Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Solid Formulations Drug Delivery market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powders Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Solid Formulations Drug Delivery include Pfizer, Teva Pharmaceuticals, Bristol Myers Squibb, Lead Chemical, Purdue Pharma, Glenmark Pharmaceuticals, Galderma, Johnson & Johnson Private and GlaxoSmithKline, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Solid Formulations Drug Delivery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Solid Formulations Drug Delivery Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Solid Formulations Drug Delivery Market Segment Percentages, by Type, 2021 (%)
Global Solid Formulations Drug Delivery Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Solid Formulations Drug Delivery Market Segment Percentages, by Application, 2021 (%)
- Home Care Settings
- Hospitals & Clinics
- Burn Centers
- Other Facilities
Global Solid Formulations Drug Delivery Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Solid Formulations Drug Delivery Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Solid Formulations Drug Delivery revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Solid Formulations Drug Delivery revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Pfizer
- Teva Pharmaceuticals
- Bristol Myers Squibb
- Lead Chemical
- Purdue Pharma
- Glenmark Pharmaceuticals
- Galderma
- Johnson & Johnson Private
- GlaxoSmithKline
- Bausch Health Companies
- Hisamitsu Pharmaceuticals
- Cipla
- Bayer
- Viatris
- 3M
- Merck & Co
- Crescita Therpeautics
- Novartis International
- Boehringer Ingelheim
